GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chengdu Kanghong Pharmaceutical Group Co Ltd (SZSE:002773) » Definitions » Shiller PE Ratio

Chengdu Kanghong Pharmaceutical Group Co (SZSE:002773) Shiller PE Ratio : 33.92 (As of May. 14, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Chengdu Kanghong Pharmaceutical Group Co Shiller PE Ratio?

As of today (2025-05-14), Chengdu Kanghong Pharmaceutical Group Co's current share price is ¥25.78. Chengdu Kanghong Pharmaceutical Group Co's E10 for the quarter that ended in Mar. 2025 was ¥0.76. Chengdu Kanghong Pharmaceutical Group Co's Shiller PE Ratio for today is 33.92.

The historical rank and industry rank for Chengdu Kanghong Pharmaceutical Group Co's Shiller PE Ratio or its related term are showing as below:

SZSE:002773' s Shiller PE Ratio Range Over the Past 10 Years
Min: 22.73   Med: 28.57   Max: 36.72
Current: 33.92

During the past years, Chengdu Kanghong Pharmaceutical Group Co's highest Shiller PE Ratio was 36.72. The lowest was 22.73. And the median was 28.57.

SZSE:002773's Shiller PE Ratio is ranked worse than
68.76% of 525 companies
in the Drug Manufacturers industry
Industry Median: 24.6 vs SZSE:002773: 33.92

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Chengdu Kanghong Pharmaceutical Group Co's adjusted earnings per share data for the three months ended in Mar. 2025 was ¥0.430. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ¥0.76 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Chengdu Kanghong Pharmaceutical Group Co Shiller PE Ratio Historical Data

The historical data trend for Chengdu Kanghong Pharmaceutical Group Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chengdu Kanghong Pharmaceutical Group Co Shiller PE Ratio Chart

Chengdu Kanghong Pharmaceutical Group Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 26.78 28.83 26.94

Chengdu Kanghong Pharmaceutical Group Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.70 30.92 29.59 26.94 32.74

Competitive Comparison of Chengdu Kanghong Pharmaceutical Group Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Chengdu Kanghong Pharmaceutical Group Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chengdu Kanghong Pharmaceutical Group Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chengdu Kanghong Pharmaceutical Group Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Chengdu Kanghong Pharmaceutical Group Co's Shiller PE Ratio falls into.


;
;

Chengdu Kanghong Pharmaceutical Group Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Chengdu Kanghong Pharmaceutical Group Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=25.78/0.76
=33.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chengdu Kanghong Pharmaceutical Group Co's E10 for the quarter that ended in Mar. 2025 is calculated as:

For example, Chengdu Kanghong Pharmaceutical Group Co's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.43/115.1156*115.1156
=0.430

Current CPI (Mar. 2025) = 115.1156.

Chengdu Kanghong Pharmaceutical Group Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201506 0.077 99.500 0.089
201509 0.139 100.500 0.159
201512 0.170 100.600 0.195
201603 0.116 102.200 0.131
201606 0.087 101.400 0.099
201609 0.154 102.400 0.173
201612 0.215 102.600 0.241
201703 0.169 103.200 0.189
201706 0.092 103.100 0.103
201709 0.208 104.100 0.230
201712 0.254 104.500 0.280
201803 0.231 105.300 0.253
201806 0.119 104.900 0.131
201809 0.220 106.600 0.238
201812 0.220 106.500 0.238
201903 0.240 107.700 0.257
201906 0.150 107.700 0.160
201909 0.240 109.800 0.252
201912 0.192 111.200 0.199
202003 0.202 112.300 0.207
202006 0.178 110.400 0.186
202009 0.280 111.700 0.289
202012 -0.970 111.500 -1.001
202103 0.250 112.662 0.255
202106 0.210 111.769 0.216
202109 0.250 112.215 0.256
202112 -0.250 113.108 -0.254
202203 0.320 114.335 0.322
202206 0.260 114.558 0.261
202209 0.240 115.339 0.240
202212 0.160 115.116 0.160
202303 0.300 115.116 0.300
202306 0.270 114.558 0.271
202309 0.330 115.339 0.329
202312 0.240 114.781 0.241
202403 0.410 115.227 0.410
202406 0.340 114.781 0.341
202409 0.310 115.785 0.308
202412 0.240 114.893 0.240
202503 0.430 115.116 0.430

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Chengdu Kanghong Pharmaceutical Group Co  (SZSE:002773) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Chengdu Kanghong Pharmaceutical Group Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Chengdu Kanghong Pharmaceutical Group Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Chengdu Kanghong Pharmaceutical Group Co Business Description

Traded in Other Exchanges
N/A
Address
No.36, West Road, Jinniu District, Sichuan, Chengdu, CHN, 610036
Chengdu Kanghong Pharmaceutical Group Co Ltd is a pharmaceutical company. The company is engaged in the research and development, production, and sales of medicine, chemical medicine, and biological products.
Executives
Ke Xiao Directors, executives
Zhong Jian Jun Directors, executives
Yin Jin Qun Directors, executives
Ke Zun Hong Director
Zhong Jian Rong Directors, executives
Gong Wen Xian Supervisors
Yuan Si Xu Supervisors
Zhao Xing Ping Directors, executives
Hao Xiao Feng Directors, executives

Chengdu Kanghong Pharmaceutical Group Co Headlines

No Headlines